±±¾©Ê¦·¶´óѧϸ°ûÉúÎïѧÊÔÌâÀúÄê»ã×Ü£¨²©Ê¿£©2001Äê-1990Äê(ȱ1997Äê,1998Äê) Cc, `}SP
Ò»¡¢ Ãû´Ê½âÊÍ£º W{rt8^1
1£® ͬԴºÐ£¨homeobox£©£¨96¡¢99¡¢91£© 'D%w|Pe?Q
2£® PCR£¨96£© 2"d!(J6}K
3£® ·ºËØ£¨ubquitin£©£¨96£© hAjM1UQ,Y
4£® °é·Ö×Ó£¨chapron£©£¨96£© F|HJH"2*&q
5£® ת¼Òò×Ó£¨trascription factor£©£¨96£© 5&e<#"
6£® DG£IP3£¨96£© 03iv3/{H
7£® »ùÒòÇóý£*****ene knock out£©£¨96¡¢00£© [M%9_CfZOy
8£® ΢¹Ü×éÖ¯ÖÐÐÄ£¨MTOC£©£¨96¡¢01£© o8Z[+;
9£® ¶ËÁ£Ã¸£¨telomerase£©£¨96£© 2EK%N'H
10£® µ°°×·ÖÑ¡£¨protein sorting£©£¨96¡¢99¡¢00£© 7rC uu *M
11£® Transformation£¨92£© 7 uarh!
12£® TransfectionתȾ£¨92£© QERU5|.wc
13£® Transcytosis×ªÒÆ×÷Óã¨92£© &l?+3$q
14£® Transductionתµ¼£¨92£© 5c;h&
15£® Transdetermination£¨92£© \bx~*FaX
16£® Transdifferentiation£¨92£© "z*:'8;E
17£® Transgenic animalת»ùÒò¶¯Î92£© q,2]5'
18£® Rb£1£¨92£© 5
eA8niq#
19£® P53£¨92¡¢91£© JN
FIT;L
20£® C£jun£¨92£© 1,V`8 [
21£® ΢¹Û½áºÏµ°°×MAPS£¨99¡¢91£© gs
W0
22£® °ûÄÚÌ壨99£© sIl33kmv
23£® Cyclin dependent kinase inhibitor(CDKI)(99) (.Lrmf@hI7
24£® G£protein£¨91£© <q,+ON\'
25£® Restriction point£¨91£© I=O
y-
26£® Antipost£¨91£© Ft@Wyo`^
27£® Capping£¨91£© K{l5m{:%
28£® TATAbox£¨91£© xc?}TPpt
29£® cDNA library£¨90£© - /c7nF
30£® Aritotic apparatus£¨90£© dS`Bk6Y
31£® ¿çĤÐźŠtransmembrane signal£¨90£© {$M;H+Foh
32£® ´ÙÓÐË¿·ÖÁÑÔ mitogen£¨90£© T#O??3/%$1
33£® Nuclear lamina£¨90£© b8f+,2Tk
34£® ϸ°ûµòÍö£¨apotosis£©£¨00£© YGsS4ia*4i
35£® ϸ°ûÍâ»ùÖÊ£¨00¡¢01£© c
{I"R8
36£® ϸ°û·Ö»¯£¨00£© * \HRw +cL
37£® ϸ°ûÐźÅתµ¼£¨signal transduction£©£¨00£© {5%/ T,
38£® ¿Ë¡£¨00£© d/7l efF
39£® »ùÒò×飨00£©
0v^:
40£® Caspase£¨00£© s{/qS3=
41£® ת¼Òò×Ó£¨00£© x"(9II*
42£® ÅßÌ¥¸Éϸ°û£¨01£© 1'G8o=~
43£® ¼¤¹â¹²¾Û½¹ÏÔ΢¾µ£¨01£© yZJ*dadAr
44£® DNAоƬ£¨01£© N*DhjEU)[
¶þ¡¢ ÎÊ´ðÌ⣺ yoqa@ V
1£® ÊÔÊöÀÒ°±Ëáµ°°×¼¤Ã¸ÊÜÌåµÄÐźÅͨ·£¨96£© tLc
El'Eo
2£® ÊÔ¾ÙÀý˵Ã÷ÐÅʹϵͳÖÐÓëϸ°ûÔöÖ³Óйصļ¤Ã¸¼°Æä¹¦ÄÜ£¨95£© v&3O&y/1v
3£® ÊÔ·ÖÎöÐźÅתµ¼£¨transduction£©µÄ¼¸Ìõͨ·µÄ¹²ÐÔÓëÌØÐÔ£¨92£© :k46S<RE
4£® µ°°×ÖʵÄÁ×ËữÓëÈ¥Á×ËữÔÚϸ°ûÐźÅϵͳ´«µ¼ÖеÄ×÷Óã¨93¡¢99£© T`$KeuL
5£® ÊÔÊöÁ×õ¥Ë®½âøC£¨PLC£©µÄ·ÖÀ༰ÔÚϸ°ûÐźÅתµ¼ÖеÄ×÷Óᣣ¨01£© 2r];V'r
6£® ÊÔÊöϸ°û½ÓÊÜ»¯Ñ§Ðźźóµ÷½Ú»ùÒò±í´ïµÄ;¾¶£¨94£© 8o)L,{yl
7£® ÊÔÊöϸ°ûÖÜÆÚ¸÷½×¶ÎÖÐCyclins£CdksµÄµ÷¿Ø×÷Óã¨96£© Vos?PqUi 4
8£® ¾ÙÀý˵Ã÷CKIÔÚϸ°ûÔöÖ³µ÷¿ØÖеÄ×÷Óã¨96£© hbuZaxo<
9£® ÏêÊöcyclins£cdksϵͳÔÚϸ°ûÖÜÆÚG2/M¼°M/G1¹ý¶ÈÖÐÈçºÎÊܵ½µ÷¿ØµÄ£¿ÒÑÖªÄÇЩ·Ö×Ó¿ÉÄÜÊÇcdksµÄµ×Îï¼°ÆäÔÚÁ×ËữÓëÈ¥Á×Ëữ¹ý³ÌÖжÔϸ°û½á¹¹Ó빦Äܱ仯µÄÓ°Ï죨95£© oTOfK}
10£® Cdc2ºÍcyclin»ùÒò£¨cdc13£©ÈçºÎµ÷¿ØÏ¸°ûÖÜÆÚÔËתµÄÏÖ´ú¸ÅÄ92¡¢94£© 4FA|[An
11£® Ϊʲô˵µ°°×ÖÊÁ×Ëữ£È¥Á×ËữºÍ·ºËؽ鵼µÄµ°°×ÖÊË®½â£¨UPP£©µÄ»¥Ïàе÷ÍÆ¶¯Ï¸°ûÖÜÆÚµÄÔËת£¿£¨01£© xKp0r1}
12£® ϸ°ûÔöÖ³µ÷¿ØµÄ·Ö×Ó»úÖÆ£¨00£© Q2C)tVK+
13£® ϸ°û¹Ç¼ÜÔÚϸ°ûÔöÖ³ÖÜÆÚÖеÄ×÷Óã¨00£©
U
5`y
14£® P34cdc2µÄÐÔÖʼ°Æä×÷Óõ×ÎïÊÇʲô£¿½«ÒýÆðºÎÖÖЧӦ£¿£¨91£© =LZ>su
15£® ϸ°ûÓÐË¿·ÖÁÑÖзĴ¸Ìå΢¹ÜµÄ¶¯Á¦Ñ§±ä»¯»úÀí¼°ÆäÓëȾɫÌåÔ˶¯µÄ¹ØÏµ£¨95£© \iMyo
16£® ΢¹ÜµÄ×é×°ÓëÈ¥×é×°ÔÚϸ°ûÓÐË¿·ÖÁѹý³ÌÖеĶ¯Ì¬±ä»¯¼°Æä×÷Óã¨92£© L2Ux9_S
17£® ϸ°ûÓÐË¿·ÖÁѹý³ÌÖзĴ¸ÌåµÄ×é×°ÓëÈ¥×é×°µÄ¶¯Ì¬±ä»¯¼°Æä¹¦ÄÜ£¨93£© @)sc6
*lnW
18£® ϸ°ûÓÐË¿·ÖÁѺóÆÚȾɫÌå·ÖÀëÇ÷ÏòÁ½¼«µÄ»úÀíÊÇÈçºÎÖ¤Ã÷µÄ£¿£¨90£© vmKTF!;
19£® ÊÔÊöÖÐÐÄÁ£/¶¯Á£È¥ÔÚϸ°ûÓÐË¿·ÖÁÑÖеÄ×÷Óã¨99£© 5_G'68;OV
20£® KinetochoreÊÇÓÉÄļ¸ÖÖÖ÷Òªµ°°××é³É£¬ÓÃʲô·½·¨Ñо¿Æä¶¨Î»¡¢·Ö×ÓÁ¿¼°»úÄÜ£¿£¨90£© J5T=!wF (
21£® ÊÔ·Ö±ðÐðÊöÈËÀà×ÅË¿Á£ºÍ¶¯Á£µÄ»ù±¾×é³É¼«ÆäĿǰËùÖªµÄ¹¦ÄÜ£¨01£© R}J-nJlb
22£® ÊÔÊöϸ°û±à³ÌÐÔËÀÍö£¨programmed cell death£©ºÍϸ°ûµòÍö£¨apoptosis£©µÄÌØÕ÷ºÍÉúÀíѧÒâÒå¼°Æä¿ÉÄܵĻùÒòµ÷¿Ø£¬ÄãÈÏΪÑо¿µÄÖØµãÓ¦·ÅÔں䦣¿ÎªÊ²Ã´£¿£¨95£© .]Ybp2`"U
23£® ApoptosisÓëneerosisµÄ¼ì²âÓëÇø±ð£¨99£© J1-):3A
24£® ÈçºÎ¼ø±ðϸ°ûµòÍöÓ뻵ËÀ¡£Ï¸°ûµòÍöÑо¿µÄÖØÒªÒâÒåÊÇʲô£¿£¨01£© Pi%tsKk%
25£® ÊÔÊöunipintin£proteasen proteolytic system£¨99£© F7uhuqA]N
26£® ÒÑÖªÓÐÄÇЩÖ÷ÒªµÄ°©»ùÒòÓëÒÖ°©»ùÒòÓëϸ°ûÖÜÆÚµÄµ÷¿ØÓйأ¿²¢¾ÙÀý˵Ã÷£¨93£© P`sN&Y~m
27£® Oncogene¼°Æä²úÎïÓëϸ°ûÔöÖ³µÄ¹ØÏµ£¨91£© *IlQ5+3I
28£® ¾ÙÀý˵Ã÷oncogene¡¢growth factors¼°ÊÜÌåÖ®¼äµÄÁªÏµ£¨90£© }W
"(cYN_
29£® ÊÔÊöºáÎÆ¼¡¡¢Ï¸°ûÄÚ´Öϸ˿Á½·Ö×ӵĽṹ¡¢¸÷ÖÖÖ÷Òªµ°°×³É·ÖÔÚ¼¡ÈâÊÕËõÖеÄ×÷Óᣣ¨90£© fH!=Zb_
{8
30£® ÊÔÊöϸ°ûÖÊÃþÉÏĤµ°°×µÄ¼¸ÖÖÀàÐͼ°Æä¹¦ÄÜ£¨95£© Ck(.N
31£® ÊÔÊöÃâÒßѧ¼¼ÊõÔÚϸ°ûÉúÎïѧÑо¿ÖеÄÓ¦Óã¨92£© #D:RhqjK
32£® ͬԴºÐµÄ·¢ÏÖ¼°ÆäÔÚÉúÎïÖеÄÖØÒªÒâÒ壨92£© 4
?
{*(
33£® ÈçÒÑ֪ijһ»ùÒòƬ¶ÎÐòÁкÍÒÑ»ñµÃijһµ¥¿Ë¡¿¹ÌåÓ¦ÓúÎÖÖ¼¼Êõ·Ïߵõ½ËüµÄcDNA¿Ë¡£¨94£© 5}SXYA}
34£® ¾ÙÀý˵Ã÷ÃâÒßÓ«¹âFISH¡¢ÃâÒߵ羵ÖîÏî¼¼ÊõµÄ»ù±¾ÔÀí¼°ÆäÔÚϸ°ûÉúÎïѧÑо¿Öеĸ÷½â¾öʲôÎÊÌ⣨94£© {gIEZ{
35£® ÄãµÄ˶ʿÂÛÎÄÌá³öÁËʲôÎÊÌ⣿ÈçºÎ½â¾öµÄ£¿½áÂÛÊÇʲô£¿£¨96¡¢94¡¢00£©